http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105193806-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4745 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2015-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-01-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-01-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105193806-B |
| titleOfInvention | New application of the lycorine as HMGB1 protein inhibitor |
| abstract | New application the invention discloses lycorine as HMGB1 protein inhibitor.The lycorine includes lycorine or its hydrate or pharmaceutically acceptable salt.The present invention passes through serial experiment, demonstrating lycorine has stronger inhibiting effect to HMGB1 albumen, it can be used as the inhibitor of HMGB1 albumen, by lowering HMGB1 protein level, reach treatment because HMGB1 protein expression extremely caused by disease such as Huppert's disease etc., be expected to be developed as novel anti-tumor drug. |
| priorityDate | 2015-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 260.